In Ad‐Ctrl group, tumours displayed rapid and continued outgrowth during the course of the experiment, and the tumour volume and weight were significantly inhibited in Ad‐CAIXpromotor‐AIM2 treatment group (Figure 5C‐E). This evidence concerns the gene AIM2 and neoplasm.